Clinical Trials Directory

Trials / Terminated

TerminatedNCT02923830

Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
28 (actual)
Sponsor
TriHealth Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.

Detailed description

The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline. These complications include partial or complete obstruction, infection of the central line, and/or the onset of heparin induced thrombocytopenia.

Conditions

Interventions

TypeNameDescription
OTHERHeparinized saline catheter flushThe control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months
DRUGSaline-only catheter flushThe intervention group will have their port catheters flushed with saline only.

Timeline

Start date
2016-04-01
Primary completion
2017-11-01
Completion
2019-03-26
First posted
2016-10-05
Last updated
2019-06-11
Results posted
2019-06-11

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02923830. Inclusion in this directory is not an endorsement.